The clinical potential of NSAIDs, or dual COX/LOX inhibitors (e.g., licofelone), in combination with immunotherapy to reduce the risk of colorectal cancer liver metastasis warrants further investigation. The gene discussed is LOX; the disease is colorectal cancer.